FDA Warns Against Concurrent Use Of Triptans With SSRIs/SNRIs
The agency has received reports of serotonin syndrome caused by use of the migraine therapy class with antidepressants, according to a public health advisory.
The agency has received reports of serotonin syndrome caused by use of the migraine therapy class with antidepressants, according to a public health advisory.